Beckman Coulter Receives FDA Clearance of AccuTnI+3 Troponin I Assay on UniCel DxI Immunoassay Systems

Cardiac Disease Management Assay Available on Entire Immunoassay Portfolio

 

October 3, 2013
blood testing cath lab beckman coulter danaher

Following the June 2013 clearance of the Access AccuTnI+3 troponin I assay on Beckman Coulter's Access 2 immunoassay analyzer, the troponin assay is now cleared for use on all of the company's immunoassay systems, as well as the UniCel DxC integrated chemistry and immunoassay series.

For more information: www.beckmancoulter.com, www.danaher.com